Nestle invests big for new chances in food market

Nestle Health Sciences, a subsidiary of Nestle SA, together with Galderma, Nestle Skin Health's medical solution unit, invested more than one billion yuan ($158 million) on Tuesday in their two new factories in Taizhou of East China's Jiangsu province.

The move is planned to help Nestle better reach Chinese consumers, by meeting their demands in the areas of special medical purposes and skin care products.

It adds to the firm's existing industrial setup and underscores Nestle's confidence in the future prospects of the Chinese market, according to Nestle. Currently, Nestle has 33 factories and nearly 50,000 employees in China.